Portal Instruments and Takeda Partner Together for Needle-Free Drug Delivery Device

Takeda Pharmaceutical and Portal Instruments are partnering together to develop a needle-free drug delivery device for Takeda’s biologic medicines. Portal will provide a reusable, needle-free device that will administer Takeda’s drug for ulcerative colitis and Crohn’s disease that is currently administered via intravenous infusion.

“This partnership allows us to work collaboratively with Takeda’s highly experienced R&D team and provides the first opportunity to introduce the Portal device to patients, a pivotal step as we continue to expand its potential and grow our business,” says Portal CEO Patrick Anquetil.

Read More at Fierce Biotech


 

A letter from Portal CEO, Patrick Anquetil, announces a new partnership with Takeda Pharmaceutical. Portal is driven to enhance the lives of patients by creating a stress-free and easy experience when receiving therapies for their illnesses.  This new partnership is a chance to bring their research to life in a real world application and help patients.

Read More at Portal Instruments

Latest

On a Roll: The Right Adhesives for Roll Coating in Mattress Manufacturing
April 20, 2021
On a Roll seeks to answer the questions of, “Why roll coat?” and, “What adhesives should mattress manufacturers use?” Sharing his expertise is Steve Adams, Business Manager at Worthen Industries. In mattress Read more
Will Chipotle’s Investment In Education Pay Off For Its Employees?
April 20, 2021
Chipotle launched its new debt-free tuition program for its employees. The program will cover those majoring in agriculture, culinary, and hospitality industries. The move shows intention for how the QSR values Read more
Track to the Future: Array Technologies Achieves ISO 9001:2015 Certification
April 20, 2021
Array Technologies recently completed its ISO audits and ISO certification. This exciting step in Array Technologies' growth was the main topic of conversation for this episode of Track to the Future. Travis Read more